anakinra drug pathway 2012-04-26T03:26:25Z Anakinra is a recombinant, non-glycosylated version of the human interleukin-1 (Il-1) receptor antagonist used for the treatment of inflammation associated with rheumatoid arthritis. Like the natural antagonist, anakinra competitively inhibits binding of interleukin-1 to its receptor and the subsequent effects of this potent pro-inflammatory cytokine. PW:0000929 kineret drug pathway pathway vpetri immunosuppressant drug pathway